These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 30327539)

  • 1. Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions.
    Reisberg S; Krebs K; Lepamets M; Kals M; Mägi R; Metsalu K; Lauschke VM; Vilo J; Milani L
    Genet Med; 2019 Jun; 21(6):1345-1354. PubMed ID: 30327539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.
    Yu MHC; Chan MCY; Chung CCY; Li AWT; Yip CYW; Mak CCY; Chau JFT; Lee M; Fung JLF; Tsang MHY; Chan JCK; Wong WHS; Yang J; Chui WCM; Chung PHY; Yang W; Lee SL; Chan GCF; Tam PKH; Lau YL; Tang CSM; Yeung KS; Chung BHY
    PLoS Genet; 2021 Feb; 17(2):e1009323. PubMed ID: 33600428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the capability of massively parallel sequencing for opportunistic pharmacogenetic screening.
    Ng D; Hong CS; Singh LN; Johnston JJ; Mullikin JC; Biesecker LG
    Genet Med; 2017 Mar; 19(3):357-361. PubMed ID: 27537706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now.
    Weitzel KW; Cavallari LH; Lesko LJ
    Pharm Res; 2017 Aug; 34(8):1551-1555. PubMed ID: 28466392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An optimized prediction framework to assess the functional impact of pharmacogenetic variants.
    Zhou Y; Mkrtchian S; Kumondai M; Hiratsuka M; Lauschke VM
    Pharmacogenomics J; 2019 Apr; 19(2):115-126. PubMed ID: 30206299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic content of commercial genome-wide genotyping arrays.
    Lemieux Perreault LP; Zaïd N; Cameron M; Mongrain I; Dubé MP
    Pharmacogenomics; 2018 Oct; 19(15):1159-1167. PubMed ID: 30272537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated Pharmacogenomic Reports for Clinical Genome Sequencing.
    Klanderman BJ; Koch C; Machini K; Parpattedar SS; Bandyadka S; Lin CF; Hynes E; Lebo MS; Amr SS
    J Mol Diagn; 2022 Mar; 24(3):205-218. PubMed ID: 35041930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
    Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
    J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array.
    Johnson JA; Burkley BM; Langaee TY; Clare-Salzler MJ; Klein TE; Altman RB
    Clin Pharmacol Ther; 2012 Oct; 92(4):437-9. PubMed ID: 22910441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.
    Bielinski SJ; Olson JE; Pathak J; Weinshilboum RM; Wang L; Lyke KJ; Ryu E; Targonski PV; Van Norstrand MD; Hathcock MA; Takahashi PY; McCormick JB; Johnson KJ; Maschke KJ; Rohrer Vitek CR; Ellingson MS; Wieben ED; Farrugia G; Morrisette JA; Kruckeberg KJ; Bruflat JK; Peterson LM; Blommel JH; Skierka JM; Ferber MJ; Black JL; Baudhuin LM; Klee EW; Ross JL; Veldhuizen TL; Schultz CG; Caraballo PJ; Freimuth RR; Chute CG; Kullo IJ
    Mayo Clin Proc; 2014 Jan; 89(1):25-33. PubMed ID: 24388019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpreting and Implementing Clinical Pharmacogenetic Tests: Perspectives From Service Providers.
    Hachad H; Ramsey LB; Scott SA
    Clin Pharmacol Ther; 2019 Aug; 106(2):298-301. PubMed ID: 31162629
    [No Abstract]   [Full Text] [Related]  

  • 12. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
    Hafner S; Haubensak S; Paul T; Zolk O
    Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
    [No Abstract]   [Full Text] [Related]  

  • 13. Preemptively Precise: Returning and Updating Pharmacogenetic Test Results to Realize the Benefits of Preemptive Testing.
    Haidar CE; Relling MV; Hoffman JM
    Clin Pharmacol Ther; 2019 Nov; 106(5):942-944. PubMed ID: 31520409
    [No Abstract]   [Full Text] [Related]  

  • 14. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
    Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
    Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene-drug pairs across ambulatory care settings.
    Cicali EJ; Weitzel KW; Elsey AR; Orlando FA; Vinson M; Mosley S; Smith DM; Davis R; Drum L; Estores D; Franciosi JP; Hagen MG; Jerkins GJ; Mercado ES; Nainaparampil J; Padron A; Rosenberg EI; Wright A; Schmidt SO; Mathews CA; Cavallari LH; Johnson JA
    Genet Med; 2019 Oct; 21(10):2264-2274. PubMed ID: 30926959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of Preemptive Pharmacogenetic Information on Clinical Outcome.
    Roden DM; Van Driest SL; Mosley JD; Wells QS; Robinson JR; Denny JC; Peterson JF
    Clin Pharmacol Ther; 2018 May; 103(5):787-794. PubMed ID: 29377064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Implementation of Pharmacogenetic Testing in a Hospital of the Spanish National Health System: Strategy and Experience Over 3 Years.
    Borobia AM; Dapia I; Tong HY; Arias P; Muñoz M; Tenorio J; Hernández R; García García I; Gordo G; Ramírez E; Frías J; Lapunzina P; Carcas AJ
    Clin Transl Sci; 2018 Mar; 11(2):189-199. PubMed ID: 29193749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of whole-genome sequencing-based pharmacogenetic profiling.
    Caspar SM; Schneider T; Stoll P; Meienberg J; Matyas G
    Pharmacogenomics; 2021 Feb; 22(3):177-190. PubMed ID: 33517770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APF2: an improved ensemble method for pharmacogenomic variant effect prediction.
    Zhou Y; Pirmann S; Lauschke VM
    Pharmacogenomics J; 2024 May; 24(3):17. PubMed ID: 38802404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics in Italy: current landscape and future prospects.
    Floris M; Moschella A; Alcalay M; Montella A; Tirelli M; Fontana L; Idda ML; ; Guarnieri P; Capasso M; Mammì C; Nicoletti P; Miozzo M
    Hum Genomics; 2024 Jul; 18(1):78. PubMed ID: 38987819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.